CLINICAL_TRIALS
trial_result
· 2011-10-07
Clinical Trial Update: T Cell Vaccination in Patients With Progressive Multiple Sclerosis [Phase 1, Phase 2]
Summary
Completion of Phase 1/2 trials evaluating a T cell vaccination approach for progressive multiple sclerosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hadassah Medical Organization | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: COMPLETED